New drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors
Version 2 2024-05-30, 15:38
Version 1 2014-10-28, 09:44
journal contribution
posted on 2024-05-30, 15:38 authored by M Maes, Z Fišar, M Medina, G Scapagnini, G Nowak, Michael BerkMichael BerkNew drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors
History
Journal
InflammopharmacologyVolume
20Pagination
127-150Location
SwitzerlandISSN
0925-4692eISSN
1568-5608Language
enPublication classification
C1.1 Refereed article in a scholarly journalCopyright notice
2012, Springer Basel AGIssue
3Publisher
Springer Science and Business Media LLCPublication URL
Usage metrics
Categories
No categories selectedKeywords
AnimalsAntioxidantsDepressionDisease ProgressionDrug Delivery SystemsGlycogen Synthase Kinase 3HumansImmunity, CellularInflammation MediatorsMitochondriaNF-E2-Related Factor 2NitrosationOxidative Stress119999 Medical and Health Sciences not elsewhere classified970111 Expanding Knowledge in the Medical and Health Sciences
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC